| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |